...
机译:第1线-1反向转移介导的子宫内膜异位症相关卵巢癌的DNA转导
Department of Pathology and Laboratory Medicine University of British Columbia;
Department of Molecular Oncology BC Cancer Agency;
Department of Pathology and Laboratory Medicine University of British Columbia;
Department of Molecular Oncology BC Cancer Agency;
Department of Pathology and Laboratory Medicine University of British Columbia;
Department of Pathology and Laboratory Medicine University of British Columbia;
Department of Human Genetics McGill University Research Institute of the McGill University Health;
Department of Molecular Oncology BC Cancer Agency;
Department of Molecular Oncology BC Cancer Agency;
Department of Molecular Oncology BC Cancer Agency;
Department of Pathology and Laboratory Medicine University of British Columbia;
Department of Pathology and Laboratory Medicine University of British Columbia;
Endometriosis associated ovarian cancers; Endometrioid ovarian cancer; Clear cell ovarian cancer; LINE-1 retrotransposon; LINE1-mediated DNA transduction; TTC28-L1;
机译:第1线-1反向转移介导的子宫内膜异位症相关卵巢癌的DNA转导
机译:卵巢子宫内膜异位症和卵巢癌之间是否存在关系? 4例共存卵巢子宫内膜异位症和癌症的免疫组化剖面
机译:子宫内膜异位和卵巢癌:综合综述(子宫内膜异位和卵巢癌)
机译:子宫内膜异位症和恶性肿瘤的风险,特别是卵巢癌
机译:使用EGF和赫赛汀复合腺病毒载体增强乳腺癌和卵巢癌的转导。
机译:子宫内膜异位和卵巢癌:综合综述(子宫内膜异位和卵巢癌)
机译:子宫内膜异位症相关的子宫内膜异构体卵巢癌的分子签名与子宫内膜异位症无症的子宫内胚析卵巢癌不同
机译:γ突触核蛋白通过调节Rho信号转导途径促进乳腺癌和卵巢肿瘤细胞的转移表型